REPORT FROM THE ENS 2008 – Glatiramer acetate significantly delays progression to clinically-definite MS (CDMS) in patients with clinically-isolated syndrome (CIS), according to data from the PRECISE trial (Comi et al. Abstract 059. J Neurol 2008;255(suppl 2): 10). The results were initially reported at the American Academy of Neurology 60th annual meeting, April 16, 2008.
REPORT FROM THE ENS 2008 – Musculoskeletal disorders are common in patients with Parkinsons disease but are often inadequately managed, according to a survey conducted in the U.K. (Natalwala et al. Abstract 0216. J Neurol 2008;255(suppl 2): 52).
REPORT FROM THE ENS 2008 – Several epidemiological studies have suggested a link between vascular risk factors such as hypertension and Alzheimers disease (Tzourio. Dialogues Clin Neurosci 2007;9:61-70).
Read More
REPORT FROM THE ENS 2008 – Laquinimod, a novel immunomodulatory agent in clinical development, significantly reduces the number of gadolinium-enhancing lesions on MRI, according to the results of a phase II extension study (Comi et al. Abstract 0193. J Neurol 2008;255(suppl 2): 46).